Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.44
+0.02 (0.37%)
Jun 4, 2026, 2:33 PM EDT - Market open
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $1.34 billion as of June 4, 2026. Its market cap has increased by 38.34% in one year.
Market Cap
1.34B
Enterprise Value
1.33B
1-Year Change
38.34%
Ranking
Category
Stock Price
$5.44
Market Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $1.34B, an increase of 453.70%. That is a compound annual growth rate of 15.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 1.34B | -5.48% |
| Dec 31, 2025 | 1.42B | 17.95% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
| Jun 19, 2014 | 242.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KalVista Pharmaceuticals | 1.43B |
| Damora Therapeutics | 1.41B |
| ArriVent BioPharma | 1.39B |
| Precigen | 1.38B |
| Inhibrx Biosciences | 1.37B |
| Septerna | 1.35B |
| Immatics | 1.35B |
| Maze Therapeutics | 1.34B |